31st Mar 2010 17:00
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
We hereby inform you that on 30 March 2010, the interest of the following individuals, who are all persons discharging managerial responsibilities, in AstraZeneca PLC ordinary shares, changed as detailed below. The change in interest relates to the vesting of previously announced awards made in March 2007 under the AstraZeneca Performance Share Plan or, for Jeff Pott and Lynn Tetrault, the AstraZeneca Executive Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, the individuals concerned have now become beneficially entitled to 78% of the shares originally awarded. In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed. In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting. The interests of Jeff Pott, Lynn Tetrault and Tony Zook are in the Company's American Depositary Shares (ADSs). One ADS equals one Ordinary Share.
|
Name |
Gross Shares Awarded |
Shares Lapsed |
Shares Vested |
Shares Withheld |
Net Shares Received |
Market Price on Vesting |
|
Anders Ekblom |
3,143 |
692 |
2,451 |
0 |
2,451 |
2980p |
|
Jeff Pott |
2,973 |
655 |
2,318 |
1,046 |
1,272 |
$44.90 |
|
David Smith |
16,399 |
3,608 |
12,791 |
5,245 |
7,546 |
2980p |
|
Lynn Tetrault |
10,227 |
2,250 |
7,977 |
2,933 |
5,044 |
$44.90 |
|
Tony Zook |
40,817 |
8,980 |
31,837 |
13,098 |
18,739 |
$44.90 |
A C N Kemp
Company Secretary
31 March 2010
Related Shares:
Astrazeneca